openPR Logo
Press release

Infectious Disease Therapeutics Market Future Prediction Report By 2031

07-11-2024 01:18 PM CET | Health & Medicine

Press release from: The Insight Partners

Infectious Diasease Therapeutics

Infectious Diasease Therapeutics

Infectious Disease Therapeutics Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics.

Request Sample Pages of this Research Study at - https://www.theinsightpartners.com/sample/TIPRE00016883/?utm_source=OpenPR&utm_medium=10852

Competitive Landscape: Infectious Disease Therapeutics Market: Pfizer Inc, Gilead Sciences Inc, F. Hoffmann-La Roche Ltd, Shionogi & Co Ltd, Bayer AG, BioCryst Pharmaceuticals Inc, GSK Plc, AbbVie Inc, Merck & Co Inc, and Astellas Pharma Inc

"Infectious Disease Therapeutics Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. Report provides is a professional inclusive study on the current state for the market. Analysis and discussion of important industry like market trends, size, share, growth estimates are mentioned in the report."

According to our latest study on "Infectious Disease Therapeutics Market Forecast to 2030 - Global Analysis - by Drug Class, Indication, Route of Administration, and Distribution Channel," the infectious disease therapeutics market size was valued at US$ 1,19,708.77 million in 2022 and is expected to reach US$ 1,67,883.93 million by 2030. The market is estimated to register a CAGR of 4.3% from 2022 to 2030. The rising prevalence of infectious diseases and increasing focus on funding and R&D in infectious disease therapeutics are the key driving factors behind the market development. However, the emergence of anti-infective drug resistance and associated side effects impede the infectious disease therapeutics market growth.

The report analyses factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South and Central America after evaluating political, economic, social and technological factors affecting the short Infectious Disease Therapeutics market in these regions.

Chapter Details of Infectious Disease Therapeutics Market:
Part 01: Executive Summary
Part 02: Scope of The Report
Part 03: Infectious Disease Therapeutics Market Landscape
Part 04: Infectious Disease Therapeutics Market Sizing
Part 05: Infectious Disease Therapeutics Market Segmentation by Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis

Interested in Purchasing this Report? Click here @ https://www.theinsightpartners.com/buy/TIPRE00016883/?utm_source=OpenPR&utm_medium=10852

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Infectious Disease Therapeutics Market Future Prediction Report By 2031 here

News-ID: 3576729 • Views:

More Releases from The Insight Partners

Tissue Block Storage Market Poised for Expansion by 2031
Tissue Block Storage Market Poised for Expansion by 2031
New York, US - October 15, 2025 - A new report by The Insight Partners, titled "Tissue Block Storage Market Share, Size, Trends, and Forecast by 2031," reveals that the global market for tissue block storage is expected to grow significantly over the coming years. The forecast highlights key growth drivers, market trends, challenges, and potential opportunities. Increased global cancer cases, growth in biobanking, personalized medicine, and advancements in tissue
Tilt Sensors Market Set for Robust Growth by 2031
Tilt Sensors Market Set for Robust Growth by 2031
New York, US - October 15, 2025 - A new report from The Insight Partners, titled "Tilt Sensor Market Share, Size, Trends, and Forecast by 2031," predicts steady expansion in the global tilt sensors market over the coming years. The study provides a comprehensive analysis of market trends, drivers, challenges, and emerging opportunities, aimed at helping stakeholders make informed decisions. The forecast indicates consistent growth in market value, adoption, and
Beneficial Insects Market Forecast Will Escalate Rapidly in the Future
Beneficial Insects Market Forecast Will Escalate Rapidly in the Future
The Beneficial Insects Market is expected to register a CAGR of 12% from 2025 to 2031. Global Beneficial Insects Market 2031 Report give our customers an exhaustive and top to bottom examination of Beneficial Insects market alongside its key factors, for example, market diagram and rundown, pieces of the pie, restrictions, drivers, local examination, players, serious elements, division, and considerably more. The Beneficial Insects Market information introduced inside this report
Electrotherapy Systems Market Will Surge to Reach US$ 9.24 billion by 2031
Electrotherapy Systems Market Will Surge to Reach US$ 9.24 billion by 2031
The electrotherapy systems market size is projected to reach US$ 9.24 billion by 2031 from US$ 4.94 billion in 2024. The market is expected to register a CAGR of 9.4% during 2025-2031. Global Electrotherapy Systems Market 2031 Report give our customers an exhaustive and top to bottom examination of Electrotherapy Systems market alongside its key factors, for example, market diagram and rundown, pieces of the pie, restrictions, drivers, local examination, players,

All 5 Releases


More Releases for Infectious

Infectious Disease Therapeutics Market - Infectious Disease Solutions: Revolutio …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Infectious Disease Therapeutics Market. Infectious Disease Therapeutics Market: https://www.growthplusreports.com/report/infectious-disease-therapeutics-market/9210 The Infectious Disease Therapeutics Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the
Infectious Disease Diagnostics Market Owing to the Increasing Prevalence of Infe …
According to Precision Business Insights (PBI) latest report, the infectious disease diagnostics market is expected to be worth USD 34,599.0 million in 2022, growing at a 6.4% CAGR from 2022 to 2028. Global Infectious Disease Diagnostics Market By Product (Reagents, Kits, and Consumables, Instruments and Software & Services), By Type of Testing (Laboratory Testing and POC Testing), By Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays
Increasing Prevalence of Infectious Diseases to Augment the Point-of-Care (POC) …
Point-of-care (POC) diagnosis includes sample testing to facilitate rapid diagnosis and decide on treatment planning accordingly. Infectious diseases often need to be diagnosed early, as they can be fatal against the immune system. POC infectious disease diagnostics allows early detection of diseases and can impact the medical outcome of treatment of the disease. Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/63 The U.S. FDA (United States Food and Drug Administration) is
Infectious Disease Diagnostics Market Entry Strategies, Countermeasures, Economi …
Market Expertz has published its latest research study titled 'Global Infectious Disease Diagnostics Market Report Forecast to 2027' gives a detailed assessment of the industry to offer vital information by evaluating the prevalent trends observed in the sector. The report includes valuable market insights provided by the industry experts by way of surveys and interviews as part of primary research. The authors of the study also undertake secondary research, which
Infectious Disease Diagnostics Market
According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $14.82 billion in 2017 and is expected to reach $25.90 billion by 2026 growing at a CAGR of 6.4% during the forecast period. Some of the key factors influencing the market are increasing prevalence of infectious diseases, growing R& D activities coupled with the development of novel technologies and rising new diagnostic tests for the control of
Infectious Disease Diagnostic Market
Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Most of the standard diagnostic test kits currently available are for bacterial infections and sexually transmitted diseases. However, in future these diagnostic tests are expected to be replaced by molecular techniques. The global infectious disease diagnostic market is expected to witness significant growth during the forecast period due to increasing prevalence of infectious diseases, increased